Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Gilead Sciences’ capsid inhibitor lenacapavir has the most competitive potential in long-acting combination regimens in HIV, ...

In a session at AIDS 2024, the International AIDS Conference, global leaders and community advocates gathered to discuss why ...

Changes clinical practice: The risks and benefits of adjuvant aromatase inhibitors (AIs) should be weighed carefully, especially in postmenopausal women with early-stage, hormone-receptor positive ...

Genvoya (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) is a prescription drug used to treat HIV. Genvoya can cause side effects that range from mild to ...

Citation: SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack (2024, September 2) retrieved 20 September 2024 from https ...

Copyright 2024 The Associated Press. All Rights Reserved. It’s a worrying question for health officials in one of the richest and most developed areas of the ...

India faces a significant challenge with HIV among people who inject drugs, requiring comprehensive community-based interventions to curb its spread. Listen to Story India has the second-largest ...

HIV infections remain a burden in urban areas and among adolescent girls despite efforts to tame the epidemic, the Uganda Aids Commission (UAC) said yesterday. Presenting the latest national ...

1 Drug Research Program, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland 2 Marbio, Faculty for Fisheries, Biosciences and Economy, UiT—The Arctic University of Norway, Tromsø, Norway As ...